These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1221763)

  • 1. Proceedings: Tail rattling in aggressive mice as a measure of tranquillizing activity of drugs.
    Krsiak M
    Act Nerv Super (Praha); 1975; 17(4):225-6. PubMed ID: 1221763
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Stereospecificity of neuroleptic effects in the 10-piperazino-10, 11-dihydrodibenzo (b, f) thiepin series.
    Metysová J; Protiva M
    Act Nerv Super (Praha); 1975; 17(4):218-9. PubMed ID: 1221761
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differentiation of neuroleptic and psychosedative effects in screening].
    Ott T; Matthies H
    Acta Biol Med Ger; 1969; 22(5):815-8. PubMed ID: 5392750
    [No Abstract]   [Full Text] [Related]  

  • 4. A pharmacological model with rhesus monkeys for the prediction of selective depression of psychic functions.
    Müller-Calgan H
    Act Nerv Super (Praha); 1974 Mar; 16(1):62-4. PubMed ID: 4454946
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Isolation-induced timidity in mice as a measure of anxiolytic activity of drugs.
    Krsiak M
    Act Nerv Super (Praha); 1974; 16(4):241-2. PubMed ID: 4476166
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats.
    Chandra O; Bernard J; Matussek N
    Arzneimittelforschung; 1974 Nov; 24(11):1821-4. PubMed ID: 4480057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological characteristics of the tranquilizing action of hydiphen].
    Zainkonnikova IV; Val'dman AV; Kozlovskaia MM; Rzhevskaia GF
    Farmakol Toksikol; 1980; 43(4):334-8. PubMed ID: 7439361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can social and agonistic interactions be used to detect anxiolytic activity of drugs?
    Krsiak M; Sulcova A; Donat P; Tomasikova Z; Dlohozkova N; Kosar E; Masek K
    Prog Clin Biol Res; 1984; 167():93-114. PubMed ID: 6150490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activating component in the effect of tranquilizing agents of the benzdiazepin series].
    Vikhliaev IuI; Klygul' TA
    Farmakol Toksikol; 1971; 34(3):268-72. PubMed ID: 5568682
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of Phenigama and neuroleptics on stimulation induced by cholinolytic and sympathomimetic compounds].
    Khaunina RA
    Farmakol Toksikol; 1969; 32(3):275-7. PubMed ID: 4390254
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of rats of pinealectomy and oxypertine on spontaneous locomotor activity and blood pressure during various light schedules.
    Karppanen H; Airaksinen MM; Särkimäki I
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):93-103. PubMed ID: 4774081
    [No Abstract]   [Full Text] [Related]  

  • 12. A method for quantification of "dynamic behaviour" of experimental animals in screening the tranquilizing effect of some drugs.
    Both F; Hasan M; Glees P
    Arzneimittelforschung; 1967 Jun; 17(6):787. PubMed ID: 4971502
    [No Abstract]   [Full Text] [Related]  

  • 13. [2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine, a new psychotropic compound].
    Hoffmann I; Kuch H; Schmitt K; Seidl G
    Arzneimittelforschung; 1970 Jul; 20(7):975. PubMed ID: 5536073
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological studies on 2 phthalic acid imide derivatives].
    Tamborska E; Langwiński R
    Acta Pol Pharm; 1981; 38(2):255-61. PubMed ID: 7315470
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Interaction of neuroleptic and cholinergic drugs with central dopaminergic mechanisms.
    Kelly P; Miller RJ; Sahakian B
    Br J Pharmacol; 1974 Nov; 52(3):430P-431P. PubMed ID: 4477511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interaction between Lysoneuro and anesthetic and psychostimulating drugs].
    D'Atri G; Galimberti E; Gomarasca M; Gomarasca P
    Minerva Med; 1972 Jan; 63(2):85-105. PubMed ID: 5059840
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative studies of tranquillizing drugs.
    Hano J; Gieldanowski J; Kedzierska L; Prastowski W
    Arch Immunol Ther Exp (Warsz); 1965; 13(4):440-60. PubMed ID: 5843237
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacodynamic study of an antispasmodic and tranquilizing combination recommended in the treatment of digestive ulcers].
    Mercier J; Dessaigne S; Gavend MR; Etzensperger P; Veran J
    Pathol Biol; 1967 Apr; 15(7):441-6. PubMed ID: 4864902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.